Thyrocare Technologies Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
Key metrics
Price as of 2026-07-17
Stock price
₹520.60
Market cap
8,286 Cr
Stock P/E
54.3
P/B
14.14
Dividend yield
1.8%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 135 Cr | 283 Cr | 418 Cr | 572 Cr | 157 Cr | 334 Cr | 166 Cr | 187 Cr | 193 Cr | 217 Cr | 196 Cr | 224 Cr |
| Operating expenses (approx.) | 99 Cr | 208 Cr | 308 Cr | 425 Cr | 111 Cr | 237 Cr | 120 Cr | 125 Cr | 131 Cr | 142 Cr | 139 Cr | 145 Cr |
| EBITDA | 35 Cr | 75 Cr | 110 Cr | 147 Cr | 46 Cr | 97 Cr | 46 Cr | 62 Cr | 62 Cr | 74 Cr | 57 Cr | 79 Cr |
| OPM % | 26.3% | 26.6% | 26.2% | 25.7% | 29.5% | 29.1% | 27.6% | 33.3% | 32.3% | 34.4% | 29.0% | 35.5% |
| Other income | 0.98 Cr | 3 Cr | 6 Cr | 9 Cr | 4 Cr | 6 Cr | 4 Cr | 5 Cr | 5 Cr | 3 Cr | 5 Cr | 4 Cr |
| Interest | 0.88 Cr | 2 Cr | 3 Cr | 4 Cr | 0.99 Cr | 2 Cr | 0.60 Cr | 0.70 Cr | 0.78 Cr | 0.59 Cr | -0.09 Cr | 2 Cr |
| Depreciation | 10 Cr | 20 Cr | 34 Cr | 47 Cr | 11 Cr | 24 Cr | 17 Cr | 14 Cr | 11 Cr | 12 Cr | 22 Cr | 14 Cr |
| Profit before tax | 25 Cr | 53 Cr | 72 Cr | 96 Cr | 34 Cr | 71 Cr | 28 Cr | 48 Cr | 50 Cr | 62 Cr | 35 Cr | 64 Cr |
| Tax % | 30.9% | 29.6% | 28.6% | 27.7% | 28.3% | -28.1% | 31.9% | 53.6% | 24.3% | 23.7% | 20.9% | 24.6% |
| Net profit | 17 Cr | 38 Cr | 52 Cr | 69 Cr | 24 Cr | 90 Cr | 19 Cr | 22 Cr | 38 Cr | 48 Cr | 28 Cr | 49 Cr |
| EPS (₹) | ₹3.26 | ₹7.10 | ₹9.88 | ₹13.42 | ₹4.52 | ₹9.51 | ₹3.58 | ₹4.17 | ₹7.35 | ₹9.05 | ₹1.82 | ₹2.99 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021Standalone only | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 403 Cr | 433 Cr | 495 Cr | 589 Cr | 527 Cr | 572 Cr | 687 Cr | 829 Cr | Sign in for TTM |
| Operating expenses (approx.) | 239 Cr | 260 Cr | 311 Cr | 325 Cr | 407 Cr | 434 Cr | 482 Cr | 556 Cr | Sign in for TTM |
| EBITDA | 164 Cr | 174 Cr | 184 Cr | 264 Cr | 120 Cr | 137 Cr | 205 Cr | 273 Cr | Sign in for TTM |
| OPM % | 40.7% | 40.1% | 37.1% | 44.9% | 22.8% | 24.0% | 29.9% | 32.9% | Sign in for TTM |
| Other income | 10 Cr | 8 Cr | 12 Cr | 29 Cr | 8 Cr | 9 Cr | 15 Cr | 17 Cr | Sign in for TTM |
| Interest | 0.61 Cr | 2 Cr | 0.87 Cr | 2 Cr | 2 Cr | 4 Cr | 3 Cr | 3 Cr | Sign in for TTM |
| Depreciation | 26 Cr | 32 Cr | 30 Cr | 34 Cr | 39 Cr | 47 Cr | 55 Cr | 59 Cr | Sign in for TTM |
| Profit before tax | 137 Cr | 140 Cr | 153 Cr | 228 Cr | 87 Cr | 96 Cr | 147 Cr | 211 Cr | Sign in for TTM |
| Tax % | 38.5% | 37.2% | 25.8% | 22.6% | 27.7% | 27.7% | 37.2% | 23.7% | Sign in for TTM |
| Net profit | 85 Cr | 88 Cr | 113 Cr | 176 Cr | 64 Cr | 69 Cr | 91 Cr | 163 Cr | Sign in for TTM |
| EPS (₹) | ₹15.95 | ₹16.74 | ₹21.41 | ₹33.30 | ₹12.16 | ₹13.42 | ₹17.13 | ₹10.27 | Sign in for TTM |
| Dividend payout % | — | — | — | 45.0% | 123.3% | 137.1% | 105.0% | 91.1% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021Standalone only | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 53 Cr | 53 Cr | 53 Cr | 53 Cr | 53 Cr | 53 Cr | 53 Cr | 159 Cr |
| Reserves | 382 Cr | 314 Cr | 0.0000 Cr | 0.0000 Cr | 482 Cr | 475 Cr | 494 Cr | 427 Cr |
| Borrowings | — | — | — | — | — | 22 Cr | — | — |
| Other liabilities | 40 Cr | 103 Cr | 82 Cr | 555 Cr | 98 Cr | 95 Cr | 146 Cr | 161 Cr |
| Total liabilities | 475 Cr | 469 Cr | 528 Cr | 608 Cr | 633 Cr | 644 Cr | 693 Cr | 747 Cr |
| Fixed assets (net) | — | — | 95 Cr | — | 157 Cr | 168 Cr | 149 Cr | 206 Cr |
| CWIP | — | — | 8 Cr | — | 2 Cr | 3 Cr | 14 Cr | 3 Cr |
| Investments | — | — | 254 Cr | — | 129 Cr | 137 Cr | 137 Cr | 152 Cr |
| Other assets | — | — | 183 Cr | — | 273 Cr | 279 Cr | 338 Cr | 372 Cr |
| Total assets | 475 Cr | 469 Cr | 528 Cr | 608 Cr | 633 Cr | 644 Cr | 693 Cr | 747 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021Standalone only | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 267 Cr | 129 Cr | 168 Cr | 191 Cr | 213 Cr |
| Cash from investing | — | — | — | -120 Cr | -39 Cr | -91 Cr | -53 Cr | -23 Cr |
| Cash from financing | — | — | — | -147 Cr | -86 Cr | -85 Cr | -130 Cr | -170 Cr |
| Net cash flow | — | — | — | 0.43 Cr | 4 Cr | -8 Cr | 8 Cr | 21 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 229 Cr | 86 Cr | 106 Cr | 146 Cr | 192 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021Standalone only | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 31.7% | 38.7% | 290.3% | 435.3% | 15.2% | 16.5% | 27.4% | 36.6% |
| ROE % | 0.0% | 24.1% | 0.0% | 33.2% | 12.0% | 13.4% | 16.7% | 27.8% |
| Debtor days | — | — | 34 | — | 59 | 28 | — | — |
| Inventory days | — | — | 51 | — | 64 | 105 | 90 | 81 |
| Days payable | — | — | 48 | — | 59 | 89 | — | — |
| Cash conversion cycle | — | — | 37 | — | 64 | 44 | 90 | 81 |
| Debt / equity | — | — | — | 0.00 | — | 0.04 | 0.0027 | 0.0009 |
| Current ratio | — | — | 2.91 | — | 3.54 | 3.08 | 2.77 | 3.39 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -0.15 | 0.09 | -0.09 | -0.14 |
Compare with peers
Loading peers…